Supplementary Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Data from Surface Proteomics Reveals CD72 as a Target for In Vitro–Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL
Authors: Matthew A. Nix, Kamal Mandal, Huimin Geng, Neha Paranjape, Yu-Hsiu T. Lin, Jose M. Rivera, Makeba Marcoulis, Kristie L. White, Jeffrey D. Whitman, Sagar P. Bapat, Kevin R. Parker, Jonathan Ramirez, Anne Deucher, Paul Phojanokong, Veronica Steri, Faranak Fattahi, Byron C. Hann, Ansuman T. Satpathy, Aashish Manglik, Elliot Stieglitz, Arun P. Wiita
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362540131